Header Logo

Connection

Barish Edil to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Barish Edil has written about Protein Kinase Inhibitors.
Barish Edil
Connection Strength
0.026
Protein Kinase Inhibitors
  1. Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. 2013 Nov 01; 87(3):458-9.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.